A new charter for the Advisory Committee on Immunization Practices (ACIP), which advises the Centers for Disease Control and Prevention (CDC) on vaccine use, significantly alters the committee’s focus. The revised charter shifts away from a primary emphasis on recommending new vaccines, instead placing a greater responsibility on the committee to evaluate alternatives for disease prevention.
This change marks a departure from previous charters that prioritized vaccine research experience in member selection. The updated charter, now available on the CDC’s website, states that the panel should represent a “balanced range of scientific, clinical, and public health expertise relevant to the Committee’s mission.” This broad criterion may allow for the inclusion of members with limited backgrounds in vaccines or vaccination policy, raising questions about the potential impact on future vaccine recommendations and public health strategies.
Open the full market picture for your next decision →
